Search Results 721-730 of 18319 for Hepatitis b

1. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

   ... hepatitis B surface antigen and negative hepatitis B surface antibody) must have an undetectable hepatitis B viral load. Patients who have positive hepatitis ...

2. Sexually transmitted diseases (STDs) - Doctors and departments - Mayo Clinic

   Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually ...

3. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive); Presence of fungal, bacterial, viral, or other infection ...

4. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

   Hepatitis B surface antigen (HBsAg) positive; HBsAg negative, anti-hepatitis B surface antibody (HBs) positive and/or anti-hepatitis B core antibody (HBc) ...

5. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... hepatitis B, or hepatitis C. Note: HIV and hepatitis B or C testing is not required and subjects with serologic evidence of prior vaccination to hepatitis B ...

6. A Study to Evaluate Whether or Not Extracellular Counts and Content Can Diagnose Alcoholic Hepatitis - Mayo Clinic

   The purpose of this study is to determine if extracellular (EV) counts and content can differentiate Alcoholic Hepatitis (AH) from alcoholic liver disease ...

7. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   History of active hepatitis B infection; NOTE: There is no requirement to screen patients for hepatitis B; History of active hepatitis C infection; NOTE: There ...

8. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Other causes of liver disease (e.g., alcoholic liver disease, hepatitis B virus infection (see Appendix 3), chronic hepatitis C virus infection (see ...

9. A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...

10. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - Mayo Clinic

    Active hepatitis B infection as defined by the presence of hepatitis B surface antigen (HBsAg) or presence of hepatitis B virus DNA;; c. Hepatitis C as ...